Pirtobrutinib, a non-covalent Bruton tyrosine kinase (BTK) inhibitor, met the primary endpoint for non-inferiority in terms ...
This data is from SOTA-P-CARDIA, a prospective, randomized, double-blind, placebo-controlled trial that exclusively enrolled patients with heart failure with preserved ejection fraction (HFpEF) and ...
A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) ...
Speakers at the Institute for Value-Based Medicine event held September 18, 2025, in Nyack, New York, spoke about methods of ...
A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) ...
A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) inhibitors—such as ...
Revenue from excise duties on sugar-sweetened beverages (SSB) has been used to procure medications for diabetes and chronic kidney disease (CKD), says Health Minister Datuk Seri Dr Dzulkefly Ahmad.
Q: I’m 68 and overweight by 45 pounds. Now that GLP-1s are going to be covered by Medicare, I think I will add that to my ...
In a recent rat study, scientists found that blocking both SGLT1 and SGLT2 worked better than blocking SGLT2 alone for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback